Docebo Inc. Form 6-K Summary
Business Context and Reporting Period
Docebo Inc. filed a Form 6-K in November 2023 as a foreign private issuer reporting under Canadian securities requirements. The filing covers the three and nine months ended September 30, 2023. The company’s principal executive offices are in Toronto, Ontario, Canada.
The filing identifies, but does not reproduce, unaudited condensed consolidated interim financial statements, management’s discussion and analysis, and a November 9, 2023 press release reporting third-quarter 2023 results.
Financial Metrics
The provided filing text does not include the underlying financial statements, MD&A, or press-release financial data. Accordingly, clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, customer metrics, and other financial measures are not available from the supplied text.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial results or a clear description of material changes from the prior-year comparable period.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risk factors, contingencies, or unusual items are described in the supplied text. These matters may be addressed in the referenced MD&A or press release, which are listed as exhibits but are not included in the input.
Exhibits 99.1, 99.2, 99.4, and 99.5 are incorporated by reference into specified registration statements. The filing includes CEO and CFO interim-filings certificates under Canadian regulations.
Investor Verification Items
- Verify third-quarter and year-to-date revenue, net income or loss, adjusted metrics, and year-over-year growth in Exhibit 99.1 or Exhibit 99.3.
- Review operating cash flow, free cash flow, cash balances, debt, and liquidity commitments.
- Review the MD&A for management’s outlook, guidance, customer and subscription metrics, foreign-exchange effects, and material risks.
- Confirm any changes in margins, operating expenses, deferred revenue, contract liabilities, or stock-based compensation.
- Review the incorporated exhibits and interim certifications for management’s representations and any disclosed internal-control matters.